Ajooni Biotech Limited has informed the Exchange regarding 'Undertaking of functional website'.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajooni Biotech Limited has submitted a compliance filing to NSE confirming that their company website (www.ajoonibiotech.com) is updated and functional as required under Regulation 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates that all listed companies maintain a publicly accessible website with mandatory disclosures including financial statements, shareholding patterns, and corporate governance information. The filing dated April 10, 2026, was signed by Company Secretary Swati Vijan and submitted digitally.
This is a routine regulatory compliance disclosure confirming the company meets SEBI's website disclosure requirements. It has no direct impact on stock price or financials but demonstrates adherence to corporate governance norms, which is positive for investor confidence.